GasLog Partners (GLOP) is a limited partnership firm which owns, operates and acquires LNG carriers under long-term charter of five years or more. The company has an initial fleet of three LNG carriers with long-term contracts scheduled to expire in 2018 and 2019.
GasLog (GLOG) is the parent company of GasLog Partners. The company is an owner, operator and manager of LNG carriers and works as a part of LNG logistics chain. In April 2012, the company had a fleet of 10 LNG carriers and since then GasLog has increased its capacity by 111% to 21 fully owned ships.
This article discusses the investment positives for the recently listed GasLog Partners. The investment conclusion is that the company is a strong buy for the long term.
Key Investment Positives:�Modern Fleet with Visible Growth
GasLog Partners��initial fleet consists of three LNG carriers with contract expiry in 2018 and 2019. In addition to this, GasLog Partners has the option to purchase 12 LNG carriers over the next three years.
Hot Gas Stocks To Own For 2015: Apollo Gold Corporation(BRD)
Brigus Gold Corp. engages in the extraction, processing, refining, and production of gold and other by-product metals primarily in North America. The company principally produces gold and silver. It primarily owns the Black Fox Complex and Black Fox Mill properties located in the Timmins Mining District in the Province of Ontario, Canada; the Goldfields project located in the Lake Athabasca region of Saskatchewan, Canada; and the Ixhuatan property located in the state of Chiapas, Mexico. Brigus Gold Corp., through its joint venture, holds interests in the Ampliacion Pueblo Viejo and Loma El Mate gold exploration projects located in the Dominican Republic. The company was formerly known as Apollo Gold Corporation and changed its name to Brigus Gold Corp. in June 2010. Brigus Gold Corp. was founded in 1936 and is headquartered in Halifax, Canada.
Advisors' Opinion:- [By MONEYMORNING]
As well, Primero Mining (NYSE: PPP) bought Brigus Gold Corp (USA)(NYSE: BRD) for $220 million, and Asanko Gold (NYSEMKT: AKG) is acquiring PMI Gold Corporation (TSE: PMV).
- [By Zacks Investment Research]
It is hard to find a good play in the Zacks Industry of mining non-ferrous metals, as the industry currently has a rank of 247 out of 261. In fact, in our five mining industries, there are only two No. 1-Ranked stocks: Brigus Gold (BRD) and Impala (IMPUY.PK). Both of these are in struggling industries, but they have proven to be best-in-class thanks to improving earnings estimates. Plus, both have seen their ranks surge from holds (or worse) up to strong buy territory, suggesting either of these names might be better picks than the struggling SCCO at this time.
Top 10 Logistics Companies To Invest In Right Now: NewLink Genetics Corp (NLNK)
NewLink Genetics Corporation (NewLink), incorporated on June 4, 1999, is a development-stage company. The Company is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio includes biologic and small-molecule immunotherapy product candidates focused to treat a range of oncology indications. Its product candidate, HyperAcute Pancreas cancer immunotherapy (HyperAcute Pancreas), is being studied in a Phase-III clinical trial in surgically-resected pancreatic cancer patients that is being performed under a Special Protocol Assessment (SPA), with the United States Food and Drug Administration (FDA). It has three additional product candidates in clinical development, including its HyperAcute Lung cancer immunotherapy (HyperAcute Lung), which is being studied in a Phase-I/II clinical trial conducted at the National Cancer Institute (NCI), and its HyperAcute Melanoma cancer immunotherapy (HyperAcute Melanoma), which is being studied in an investigator-initiated Phase-II clinical trial.
The Company�� HyperAcute product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune system. It is also conducting small-molecule based research and development to produce new drugs capable of breaking the immune system's tolerance to cancer through inhibition of the indoleamine-(2,3)-dioxygenase (IDO), pathway. It is engaged in the study of IDO pathway inhibitor product candidate, d-1-methyltryptophan (D-1MT), in collaboration with the NCI, in two Phase 1B/II clinical trials.
HyperAcute Cancer Immunotherapy Product Candidates
In May 2010, the Company initiated Phase-III clinical trial for HyperAcute Pancreas. Its second product candidate, HyperAcute Lung, is in a Phase I/II clinical trial that is enrolled with 54 patients for the treatment of refractory, recurrent or metastatic nonresectable non-small cell lung cancer (NSCLC). Its Hyper! Acute Melanoma product candidate is being studied in an investigator-initiated, fully enrolled 25 patient Phase-II clinical trial for the treatment of advanced melanoma.
HyperAcute Cancer Immunotherapy Technology
The Company�� HyperAcute immunotherapies operate by exploiting a natural barrier present in humans that protects against infection being transmitted from other mammals. This barrier is related to the enzyme, alpha (1,3) galactosyl transferase, which is expressed in the cells of lower mammals. The presence of this enzyme results in the expression of a non-human form of carbohydrate called alpha (1,3) galactosyl carbohydrates (a-Gal), on the surface of affected cells. Its HyperAcute immunotherapy product candidates are composed of irradiated, live, allogeneic human cancer cells modified to express the gene that makes a-Gal epitopes. This exposure to a-Gal stimulates the human immune system to attack and destroy the immunotherapy cells on, which a-Gal is present by activating complement.
IDO Pathway Inhibitor Product Candidate
The Company is developing D-1MT, a small-molecule, orally bioavailable product candidate designed to inhibit the IDO pathway. In preclinical models, IDO pathway inhibitors have shown anti-tumor effects in combination with radiotherapy, chemotherapy, targeted therapy or immunotherapy. Through its collaboration with the NCI, it is studying D-1MT in two Phase 1B/II safety and efficacy clinical trials in various chemotherapy and immunotherapy combinations. One clinical trial combines D-1MT with an Ad-p53 autologous dendritic cell vaccine for solid malignancies with p53 mutations, such as lung, breast and colon cancers. The other clinical trial involves the combined use of D-1MT and Taxotere for patients with advanced stage solid tumors, for which Taxotere is the standard-of-care treatment, such as metastatic breast, prostate, ovarian and lung cancers.
Advisors' Opinion:- [By Ben Rooney]
NewLink Genetics (NLNK) is working with the World Health Organization and other agencies on an Ebola vaccine. Its shares have surged 57% in the past month.
- [By Jake L'Ecuyer]
In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.64 percent. Top decliners in the sector included Sunesis Pharmaceuticals (NASDAQ: SNSS), off 5.6 percent, and NewLink Genetics (NASDAQ: NLNK), down 6.3 percent.
- [By Ben Levisohn]
Biotech companies that are most likely to benefit because they are “Ahead in clinical development and/or have established relationships with [the Biomedical Advanced Research and Development Authority, or] BARDA which may facilitate getting a contract” include GlaxoSmithKline (GSK), NewLink Genetics (NLNK), Johnson & Johnson (JNJ) and Chimerix (CMRX). Kantor includes Tekmira�(TKMR) and Sarepta (SRPT) among “companies with viable programs” that are “moving forward and likely to attract additional funding.”
- [By Jayson Derrick]
NewLink Genetics (NASDAQ: NLNK) announced that it will discontinue the phase 3 IMPRESS clinical trial of algenpantucel-L for patients with pancreatic cancer. The company intends to regroup and ��athering additional, more mature data in support of our mission to provide improved treatment options for patients with pancreatic cancer.��Shares fell 16.20 percent, closing at $31.60.
Top 10 Logistics Companies To Invest In Right Now: Audience Inc (ADNC)
Audience, Inc., incorporated on May 24, 2011, is a provider of voice and audio solutions that improve voice quality and the user experience in mobile devices. The Company�� solutions include hardware-accelerated digital signal processors (DSPs), and audio codecs and associated algorithms for noise suppression in mobile devices. Its computational auditory scene analysis (CASA) maps the sound separation functions in human hearing, into a computational framework. The Company�� platform consists of its DSPs and audio codec, analog and mixed signal circuits and algorithms for voice isolation and noise suppression.
The Company also provides its AuViD graphical design tools to original equipment manufacturers (OEMs). The Company had sold over 250 million processors to its OEM customers as of December 31, 2012. In addition to the mobile device market, the Company�� voice and audio technology is also applicable to a range of other market segments, including automobile infotainment systems, digital cameras, digital televisions, headsets and set top boxes.
The Company�� product portfolio supports both analog and digital interfaces. As of December 31, 2012, the Company offered eS515, eS325, eS305, eS310, eS110, A1028 and A1026 custom voice and audio processors for device platforms, including smartphones, feature phones and media tablets. eS515 is a third generation voice and audio processor with an integrated audio codec, featuring support of three-microphones; eS325is a third generation voice and audio processor that features simultaneous three microphone processing; eS305 is a second generation voice and audio processor utilizing new hardware acceleration architecture and algorithms for far-field, wideband communications and capable of advanced speech recognition assist, and uses an all digital interface; eS310, provides similar capabilities to the eS305; eS110 is a first generation narrowband voice processor designed for real-time communications and far-field as well as near-field u! se with features such as acoustic echo cancelation, voice equalization and automatic gain control; A1026, is a first generation narrowband voice processor designed for real-time communications and typical near-field use, and A1028, which is a first generation narrowband voice processor designed for real-time communications and far-field, as well as near-field use.
The Company derives its revenue primarily from the sale of voice and audio processors to OEMs, which incorporate them into mobile devices. As of December 31, 2012, OEMs, CMs and distributors worldwide had purchased more than 250 million of its processors and incorporated them in over 140 mobile device models.
The Company competes with Maxim, ON Semiconductor, Qualcomm, Texas Instruments Incorporated, Wolfson Microelectronics plc, DSP Group, Inc. and Yamaha Corporation.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Audience (Nasdaq: ADNC ) , whose recent revenue and earnings are plotted below.
Top 10 Logistics Companies To Invest In Right Now: El Pollo Loco Holdings Inc (LOCO)
El Pollo Loco Holdings, Inc., formerly EPL Holdings, Inc., incorporated in 1999, own, operate and franchise restaurants specializing in marinated, flame-grilled chicken. During the fiscal year ended December 28, 2005 (fiscal 2005), the Company's restaurant system had 340 restaurants, consisting of 146 company-operated and 194 franchised restaurants, located principally in California, with additional restaurants in Arizona, Nevada, Texas and Illinois. In fiscal 2005, the Company closed one company-operated and one franchised restaurant and it opened six company-operated and seven franchised restaurants. The Company's restaurant is a freestanding building ranging from approximately 2,200 to 2,600 square feet with seating for approximately 60 customers and offering drive-thru convenience.
The Company's menu features flame-grilled chicken and includes approximately 50 items, most of which it prepares from scratch. The Company serves a range of individual and family-size chicken meals, which include flour or corn tortillas, salsas and a range of side orders, such as Spanish rice and pinto beans. In addition, the Company offers a range of Mexican-inspired entrees featuring marinated, flame-grilled chicken as the central ingredient, including its specialty Pollo Bowl, Pollo Salads, signature burritos, chicken quesadillas, chicken tortilla soup and chicken tacos.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
www.elpolloloco.com One of this year's hottest initial public offerings is a quick-service restaurant chain that prides itself on its grilled citrus-marinated chicken. El Pollo Loco (LOCO) has seen its stock more than double since it went public at $15 in July. The California-based eatery had its first chance to impress investors with its first quarterly report as a public company on Thursday. It didn't disappoint. Sales inched 6.3 percent higher to $86.9 million, fueled primarily by a 5.4 percent increase in system-wide comparable-restaurant sales. Adjusted earnings climbed 10 percent to $6.1 million -- or 16 cents a share. The results were in line with analyst targets of 16 cents a share in net income on $86.4 million in sales. This isn't the kind of monster growth that investors associate with stocks that double within two months of storming out of the IPO gate, but El Pollo Loco now has the ammo to begin expanding its reach beyond the 401 locations open at the end of June. For investors, El Pollo Loco offers an opportunity to cash in on the fast-casual trend that's been faring better than traditional fast-food chains or casual-dining establishments. Spreading Its Wings Going public has its challenges. It forces companies to live up to Wall Street's quarterly expectations, and that can often get in the way of carrying out long-term growth plans. However, trading publicly gives a company the ability to tap equity markets to raise capital. It also helps validate brands, and that's a pretty big deal for a consumer-facing restaurant operator that relies on third-party franchisees to help build out its empire. A majority of its eateries -- 233 locations, or 58 percent -- are owned and operated by franchisees. Expansion has been slow until now. El Pollo Loco had 347 locations when it originally tried but ultimately failed to go public in 2006. Growing your store count by 16 percent through eight years isn't very impressive. El Pollo Loco had 398 restauran
Top 10 Logistics Companies To Invest In Right Now: Pimco Corporate & Income Opportunity Fund (PTY)
PIMCO Corporate Opportunity Fund (the Fund) is a diversified closed-end management investment company. The Fund�� investment objective is to seek maximum total return through a combination of current income and capital appreciation in a diversified portfolio of United States dollar-denominated corporate debt obligations of varying maturities and other income producing securities. The Fund will normally focus on corporate debt obligations rated in the lowest investment-grade category (Baa or BBB) and in the highest non-investment-grade category (Ba or BB). Its portfolio includes corporate bonds and notes, the United States Government agency securities, sovereign debt obligations, municipal bonds, mortgage-backed securities, asset-backed securities and short-term investments.
The Fund invests in residual interest municipal bonds and residual interest tax exempt bonds (inverse floaters), whose interest rates bear an inverse relationship to the interest rate on another security or the value of an index. PIMCO Corporate Opportunity Fund may purchase and write (sell) put and call options. The Fund may sell options on the United States Treasury futures and other fixed-income instruments. PIMCO Corporate Opportunity Fund invests in various industries, including airlines, banking, energy, financial services, food and beverage, hotels/gaming, oil and gas, paper/paper products, telecommunications and utilities. The Fund's investment manager is Allianz Global Investors Fund Management LLC, which is an indirect wholly owned subsidiary of Allianz Global Investors of America L.P. PIMCO Corporate Opportunity Fund's sub-advisor is Pacific Investment Management Company LLC.
Advisors' Opinion:- [By Dan Caplinger]
Lesson 1: Income is king.
A look at the four funds trading at the highest premiums to net asset value reveals a common thread: They're all focused on maximizing income. What's interesting, though, is that they use different methods to reach the same ends. Among the three PIMCO funds, PIMCO High Income (NYSE: PHK ) looks largely to the high-yield bond market for its holdings, while PIMCO Corporate & Income Opportunities (NYSE: PTY ) has a somewhat lower distribution rate but has a sizable allocation to investment-grade debt. The fund with the highest premium, PIMCO Global StocksPLUS, uses futures contracts to add stock exposure to its portfolio of income-producing bonds. Finally, BlackRock Virginia Municipal Bond rounds out the top four with its tax-free bond portfolio.
Top 10 Logistics Companies To Invest In Right Now: Intelligent Living Inc (ILIV)
Intelligent Living Inc., formerly Feel Golf Co., Inc., incorporated on February 14, 2000, is a developer of healthy aging software tracking systems and wellness centers, which will provide integrated services promoting optimal health and wellness programs. The services to be offered by the Company are personalized programs and regimens developed by nutritionists, fitness specialists and hormone replacement therapists. The Company focuses to offer the benefits of tailored nutritional programs and its products, combined with healthy-aging bio-identical hormone replacement therapies (BHRT). The Company provides services, such as Age Management Medicine, Excercise & Nutrition, MIND360.COM, Nutraceuticals, Hormone Therapy, and Business Solutions.
Age Management Medicine
The Company's Age Management Medicine is a proactive and preventative approach to healthcare for an aging population. The basic tenets of Age Management Medicine include medical history examination of the patient, a thorough lifestyle assessment, and physical and laboratory evaluations, which are used to establish personalized treatment plans.
Business Solutions
The Company is in the development stages of launching its own Electronic Medical Records software. The product will be a Web-based clinical application for the management of patients with hormone and other chronic conditions.
Excercise & Nutrition
The Company has on-site fitness specialists and nutritionists to help one attain goals. Depending on personal goals, personalized consultations are available at their request.
Hormone Therapy
The Company works directly with a pharmacy that compounds products for hormone replacement therapy (HRT). It serves both men and women.
MIND360.COM
Mind360 enhances and maintains people�� mental fitness through an online cognitive training platform. Its engaging brain training games are designed to help strengthen ke! y cognitive functions, including memory, attention, executive functions, thinking and reasoning, and visual perception. Mind360 has over 10,000 users in every continent with more than 40 games.
Nutraceuticals
The Company is focused on optimizing health goals through proper nutrition and dietary supplementation. Its Nutraceutical products support this proactive approach to healthy aging and helps reduce the negative effects of aging and improve quality of life. The Company's Nutraceutical line of products are formulated by both pharmacists and physicians.
Advisors' Opinion:- [By Peter Graham]
Small cap healthcare and lifestyle stocks Axxess Pharma Inc (OTCMKTS: AXXE), Medefile International Inc (OTCMKTS: MDFI) and Intelligent Living Inc (OTCMKTS: ILIV) have all been getting some extra attention lately thanks in part to a few disclosed paid promotions or investor relations type of activities. But just how healthy are these small cap stocks for investors and traders alike? Here is a quick reality check:
Top 10 Logistics Companies To Invest In Right Now: KMG Chemicals Inc (KMG)
KMG Chemicals, Inc., incorporated on July 30, 1992, manufactures, formulates and globally distributes specialty chemicals. The Company has acquired and operates businesses selling electronic chemicals and industrial wood treating chemicals. The Company operates in two segments: electronic chemicals and wood treating chemicals. The Company's electronic chemicals segment provides wet process chemicals to the semiconductor industry, primarily to clean and etch silicon wafers in the production of semiconductors. The Company supplies wet process chemicals to the semiconductor industry in the United States and Europe. Its wood treating chemicals, pentachlorophenol (penta), and creosote, are sold to industrial customers who use these preservatives primarily to extend the useful life of utility poles and railroad crossties. The Company is the supplier of penta in North America, and supplier of creosote in the United States to wood treaters who do not produce their own creosote. On March 1, 2012, the Company discontinued its animal health business. In June 2013, the Company announced that it completed the acquisition of the Ultra Pure Chemicals subsidiaries of OM Group Inc located in the United States, England and Singapore.
Electronic Chemicals
The Company's electronic chemicals business sells wet process chemicals primarily to the semiconductor industry. These chemicals are used to clean and etch silicon wafers in the production of semiconductors. The Company's products include sulfuric, phosphoric, nitric and hydrofluoric acids, ammonium hydroxide, hydrogen peroxide, isopropyl alcohol and various blends of chemicals. The Company's products are sold in bulk and in containers, including bottles, drums and totes. This process is accomplished at the Company's Pueblo, Colorado, Hollister, California and Milan, Italy facilities, although the Company contracts with General Chemical to produce certain products for the Company at its facility. As of July 31, 2012, the Company's electronic ! chemicals business accounted for 58.5% of its net sales.
Wood Treating Chemicals
The Company supplies penta and creosote to industrial customers who use these products to extend the useful life of wood, primarily utility poles and railroad crossties. The Company's penta products include penta blocks, solutions and hydrochloric acid, a byproduct of penta production. Penta is used primarily to treat utility poles, protecting them from insect damage and decay. The Company manufactures solid penta blocks at its facility in Matamoros, Mexico. The Company sells solid penta to its customers, or make it into a liquid solution of penta concentrate at its Matamoros, Mexico and Tuscaloosa, Alabama facilities. The Company sells penta products primarily in the southeastern and northwestern United States and in Canada. The hydrochloric acid the Company produces as a byproduct of penta production is sold in Mexico for use in the steel and oils well service industries. Creosote is a wood preservative used to treat utility poles and railroad crossties. Creosote is produced by the distillation of coal tar, a by-product of the transformation of coal into coke. The Company sells creosote to wood treaters throughout the United States. As of July 31, 2012, the Company's wood treating chemicals constituted about 41.4% of the Company's net sales.
The Company competes with Honeywell, Kanto Corporation, Avantor, BASF and the OM Group.
Advisors' Opinion:- [By Monica Gerson]
Analysts expect KMG Chemicals (NYSE: KMG) to report its Q4 earnings at $0.27 per share on revenue of $79.00 million. KMG Chemicals shares surged 4.99% to close at $23.76 on Friday.
- [By Caroline Bennett]
J. Neal Butler, KMG Chemicals' (NYSE: KMG ) CEO and president, has resigned from his positions with the company. Effective July 10,�Christopher Fraser, KMG's chairman of the board of directors, will serve as interim replacement CEO and president, the company announced today.
No comments:
Post a Comment